Avecho Biotechnology Limited (AVEFF)

Market Cap	22.77M +63.3%
Revenue (ttm)	825.62K +9.3%
Net Income	-2.95M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Average Volume	205,981
Open	0.0045
Previous Close	0.0174
Day's Range	0.0045 - 0.0045
52-Week Range	0.0012 - 0.0174
Beta	0.91
RSI	49.24
Earnings Date	May 28, 2026

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: AVEFF

Financial Performance

In 2025, Avecho Biotechnology's revenue was 1.24 million, an increase of 9.28% compared to the previous year's 1.13 million. Losses were -4.42 million, 41.5% more than in 2024.

Financial numbers in AUD